Hemlibra Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Emicizumab

Indications/Uses

Routine prophylaxis to prevent bleeding or reduce frequency of bleeding episodes in adults & childn w/ hemophilia A (congenital factor VIII deficiency) w/ or w/o factor VIII inhibitors.

Dosage/Direction for Use

SC 3 mg/kg once wkly for the 1st 4 wk. Maintenance dose: 1.5 mg/kg once wkly, 3 mg/kg every 2 wk or 6 mg/kg every 4 wk.

Contraindications

Hypersensitivity.

MIMS Class

Haemostatics

ATC Classification

B02BX06 - emicizumab ; Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.

Regulatory Classification

POM

Presentation/Packing

Form

Hemlibra soln for inj 150 mg/mL

Packing/Price

1's

Form

Hemlibra soln for inj 30 mg/mL

Packing/Price

1's

Hemlibra

emicizumab

Manufacturer:

Chugai